Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis.
Nurmohamed
M T
MT
Soesan
M
M
van Oers
M H
MH
Dijkmans
B A
BA
van Soesbergen
R M
RM
D000368:Aged; D000741:Anemia, Aplastic / Q000139:chemically induced* / Q000188:drug therapy*; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D012460:Sulfasalazine; D016572:Cyclosporine